A 45-year-old Aboriginal woman living in a remote community has a history of acute rheumatic fever at age 12 with established moderate rheumatic mitral regurgitation. She has been on regular benzathine benzylpenicillin G injections but has been lost to follow-up. According to current Australian rheumatic heart disease guidance, what is the most appropriate secondary prophylaxis regimen for her now?